Molecular and cytogenetic characteristics of myeloid malignancies following luminal gastrointestinal cancer.

Epstein-Peterson, Zachary D; Devlin, Sean M; Stein, Eytan M; Klimek, Virginia M; Saltz, Leonard B; Tallman, Martin S

Epstein-Peterson, Zachary D; Devlin, Sean M; Stein, Eytan M; Klimek, Virginia M; Saltz, Leonard B; Tallman, Martin S.

Afiliación

Epstein-Peterson ZD; Department of Medicine, Memorial Sloan Kettering Cancer Center, USA. Electronic address: epsteinz@mskcc.org.
Devlin SM; Department of Biostatistics, Memorial Sloan Kettering Cancer Center, USA. Electronic address: devlins@mskcc.org.
Stein EM; Department of Medicine, Memorial Sloan Kettering Cancer Center, USA; Division of Hematologic Malignancies, Leukemia Service, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY, 10065, USA; Department of Medicine, Weill Cornell Medical College, 1300 York Ave, New York, NY, 10065, USA
Klimek VM; Department of Medicine, Memorial Sloan Kettering Cancer Center, USA; Division of Hematologic Malignancies, Leukemia Service, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY, 10065, USA; Department of Medicine, Weill Cornell Medical College, 1300 York Ave, New York, NY, 10065, USA
Saltz LB; Department of Medicine, Memorial Sloan Kettering Cancer Center, USA; Division of Hematologic Malignancies, Leukemia Service, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY, 10065, USA; Division of Solid Tumor Medical Oncology, Gastrointestinal Service, Memorial Sloan Kettering C
Tallman MS; Department of Medicine, Memorial Sloan Kettering Cancer Center, USA; Division of Hematologic Malignancies, Leukemia Service, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY, 10065, USA; Department of Medicine, Weill Cornell Medical College, 1300 York Ave, New York, NY, 10065, USA

Leuk Res ; 82: 19-23, 2019 07.

Article en En | MEDLINE | ID: mdl-31151028

Asunto(s)

Secuencia de Bases; ADN (Citosina-5-)-Metiltransferasas/genética; Neoplasias Gastrointestinales/genética; Neoplasias Hematológicas/genética; Trastornos Mieloproliferativos/genética; Neoplasias Primarias Secundarias/genética; Eliminación de Secuencia; Adulto; Anciano; Anciano de 80 o más Años; Antineoplásicos/uso terapéutico; Cromosomas Humanos Par 5; Análisis Citogenético; ADN Metiltransferasa 3A; Femenino; Rayos gamma/uso terapéutico; Neoplasias Gastrointestinales/diagnóstico; Neoplasias Gastrointestinales/cirugía; Neoplasias Gastrointestinales/terapia; Neoplasias Hematológicas/diagnóstico; Neoplasias Hematológicas/cirugía; Neoplasias Hematológicas/terapia; Humanos; Estudios Longitudinales; Masculino; Persona de Mediana Edad; Mutación; Trastornos Mieloproliferativos/diagnóstico; Trastornos Mieloproliferativos/cirugía; Trastornos Mieloproliferativos/terapia; Neoplasias Primarias Secundarias/diagnóstico; Neoplasias Primarias Secundarias/cirugía; Neoplasias Primarias Secundarias/terapia; Pronóstico; Estudios Retrospectivos; Riesgo; Sobrevivientes

Palabras clave

Cytogenetics; Molecular alterations; Survivorship; Treatment-related neoplasms

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Secuencia de Bases / Neoplasias Primarias Secundarias / Eliminación de Secuencia / Neoplasias Hematológicas / ADN (Citosina-5-)-Metiltransferasas / Neoplasias Gastrointestinales / Trastornos Mieloproliferativos Tipo de estudio: Diagnostic_studies / Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Leuk Res Año: 2019 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google